Lisa Wray

1.1k total citations
22 papers, 398 citations indexed

About

Lisa Wray is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Lisa Wray has authored 22 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Hematology. Recurrent topics in Lisa Wray's work include CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Lisa Wray is often cited by papers focused on CAR-T cell therapy research (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Lisa Wray collaborates with scholars based in United States and Switzerland. Lisa Wray's co-authors include Angela DeMichele, Stephan A. Grupp, Allison Barz Leahy, Anne-Marie Martin, Edward A. Stadtmauer, Amanda M. DiNofia, Regina M. Myers, Barbara L. Weber, Rosemarie Mick and Shannon L. Maude and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Lisa Wray

17 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa Wray United States	10	271	97	69	68	68	22	398
Kayla L. Nguyen United States	4	140 0.5×	310 3.2×	25 0.4×	161 2.4×	38 0.6×	10	426
A Caballero Spain	8	163 0.6×	16 0.2×	42 0.6×	46 0.7×	47 0.7×	38	314
Ranjan Tiwari India	11	186 0.7×	35 0.4×	31 0.4×	105 1.5×	38 0.6×	38	384
Jean Pierre Marie France	11	113 0.4×	124 1.3×	37 0.5×	186 2.7×	14 0.2×	19	405
Shaoyan Hu China	10	61 0.2×	59 0.6×	30 0.4×	124 1.8×	19 0.3×	77	325
Blanca Molina Spain	11	100 0.4×	56 0.6×	92 1.3×	178 2.6×	23 0.3×	31	346
Anne Marijn Kramer United Kingdom	6	217 0.8×	15 0.2×	242 3.5×	82 1.2×	49 0.7×	16	425
Muhammad Ashar Ali United States	9	73 0.3×	17 0.2×	17 0.2×	55 0.8×	30 0.4×	41	298
Suheil Albert Atallah‐Yunes United States	8	172 0.6×	19 0.2×	82 1.2×	26 0.4×	39 0.6×	22	305
Yajamanam Badrinath India	14	116 0.4×	266 2.7×	58 0.8×	298 4.4×	15 0.2×	45	548

Countries citing papers authored by Lisa Wray

Since Specialization

Citations

This map shows the geographic impact of Lisa Wray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Wray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Wray more than expected).

Fields of papers citing papers by Lisa Wray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Wray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Wray. The network helps show where Lisa Wray may publish in the future.

Co-authorship network of co-authors of Lisa Wray

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Wray. A scholar is included among the top collaborators of Lisa Wray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Wray. Lisa Wray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedman, David F., Caitlin W. Elgarten, Eugene Khandros, et al.. (2025). Post-Approval, Real-World Experience with Betibeglogene Autotemcel for Transfusion-Dependent Beta Thalassemia. Transplantation and Cellular Therapy. 31(2). S254–S254.

Elgarten, Caitlin W., Joseph H. Oved, Lisa Wray, et al.. (2025). Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies. Transplantation and Cellular Therapy. 31(10). 828.e1–828.e14.

Diorio, Caroline, Diego A. Espinoza, Brenda Banwell, et al.. (2024). Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 144(13). 1387–1398. 10 indexed citations

DiNofia, Amanda M., Yimei Li, Susan R. Rheingold, et al.. (2024). Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Advances. 9(2). 354–359. 1 indexed citations

Oved, Joseph H., et al.. (2024). Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Frontiers in Immunology. 15. 1369243–1369243.

Elgarten, Caitlin W., Joseph H. Oved, Lisa Wray, et al.. (2024). Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies. Transplantation and Cellular Therapy. 30(2). S301–S302.

Fraint, Ellen, Hisham Abdel‐Azim, Neel S. Bhatt, et al.. (2023). Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy. 29(5). 293–301. 4 indexed citations

Oved, Joseph H., et al.. (2023). Matched Sibling Donor Bone Marrow Transplant with Busulfan + Fludarabine Conditioning Results in Excellent Outcomes for Severe Congenital Neutropenia. Transplantation and Cellular Therapy. 29(2). S173–S174.

Myers, Regina M., Yimei Li, Allison Barz Leahy, et al.. (2021). Outcomes after Reinfusion of CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 474–474. 11 indexed citations

10.

Leahy, Allison Barz, Haley Newman, Yimei Li, et al.. (2021). CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials. The Lancet Haematology. 8(10). e711–e722. 77 indexed citations

11.

Leahy, Allison Barz, Yimei Li, Julie‐An Talano, et al.. (2021). Unrelated donor α/β T cell– and B cell–depleted HSCT for the treatment of pediatric acute leukemia. Blood Advances. 6(4). 1175–1185. 11 indexed citations

12.

Leahy, Allison Barz, Yimei Li, Hongyan Liu, et al.. (2021). Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy. Blood. 139(14). 2173–2185. 61 indexed citations

13.

Myers, Regina M., Julie C. Fitzgerald, Amanda M. DiNofia, et al.. (2020). Inpatient and Intensive Care Unit Resource Utilization after CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy (CART19) for Pediatric Acute Lymphoblastic Leukemia (ALL). Biology of Blood and Marrow Transplantation. 26(3). S202–S203. 6 indexed citations

14.

Newman, Haley, Yimei Li, Hongyan Liu, et al.. (2020). CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).. Journal of Clinical Oncology. 38(15_suppl). 10511–10511. 11 indexed citations

15.

Myers, Regina M., Stephan Kadauke, Yimei Li, et al.. (2020). Risk-Adapted Preemptive Tocilizumab Decreases Severe Cytokine Release Syndrome (CRS) after CTL019 CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL). Biology of Blood and Marrow Transplantation. 26(3). S39–S39. 14 indexed citations

16.

Leahy, Allison Barz, Regina M. Myers, Amanda M. DiNofia, et al.. (2019). Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy. Blood. 134(Supplement_1). 1464–1464. 9 indexed citations

17.

Vujković, Marijana, Aaron Kershenbaum, Lisa Wray, et al.. (2015). Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952. Leukemia Research Reports. 4(2). 47–50. 2 indexed citations

18.

Wray, Lisa, et al.. (2014). TPMT and MTHFR genotype is not associated with altered risk of thioguanine‐related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 61(11). 2086–2088. 10 indexed citations

19.

Smith, Karen L., Lisa Wray, Lynn M. Schuchter, et al.. (2005). Ethnic Disparities in Adjuvant Chemotherapy for Breast Cancer Are Not Caused by Excess Toxicity in Black Patients. Clinical Breast Cancer. 6(3). 260–266. 33 indexed citations

20.

DeMichele, Angela, Anne-Marie Martin, Rosemarie Mick, et al.. (2003). Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.. PubMed. 63(22). 8051–6. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact